| Application no. and date | 22740205.4 (espacenet) (Federated) (European Patent Register), 20220117 | | Patent/reg. no. and date | DK/EP 4277624, 20260114 | | Publication date | 20231122 | | Priority no. and date | US 202163138669 P, 20210118 | | EP pub. no. and date |
EP 4277624 20231122 | | Effective date | | | Applicant/owner | Biohaven Therapeutics Ltd., 215 Church Street
New Haven, CT 06510, US | | Applicant ref. no. | | | Inventor | CORIC, Vladimir,
New Haven, Connecticut 06510, US,
BERMAN, Robert,
New Haven, Connecticut 06510, US | | Representative | | | Opponent | | | IPC Class | A61K 31/428 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 9/48 (2006.01) , A61P 25/28 (2006.01) , A61P 35/00 (2006.01) | | Title | USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE | | Int. application no. | US2022012660 | | Int. publication no. | WO2022155564 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
